Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease

Byungkyu Ahn, Dong Ho Lee, Chang Min Lee, Jae Jin Hwang, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND/AIMS: Bronchiectasis is aggravated by gastroesophageal reflux disease (GERD) owing to micro aspiration. Some researchers note the effect of antireflux surgery in bronchiectasis with GERD. However, few have investigated the effects of medical antireflux therapy. We investigated the effect of proton pump inhibitors (PPIs) in bronchiectasis with GERD.

METHODS: From March 2003 to May 2015, the clinical records of patients who had bronchiectasis with GERD were reviewed. Patients underwent an initial pulmonary function test (PFT) and chest computed tomography when diagnosed with bronchiectasis. One group with typical GERD symptoms was treated with PPIs, while the other group was not. Both groups underwent PFTs within six months after completing PPI therapy. Population characteristics and associations were compared between the groups.

RESULTS: Two hundred and fifty-seven patients (124 male, 133 female; mean age 67.6±10.0 years) were included. There were no significant differences between the groups in terms of forced vital capacity (FVC; p=0.239), forced expiratory volume in one second (FEV1; p=0.555), or FEV1/FVC (p=0.374) after PPI therapy. However, there were significant improvements in FVC (p=0.002) and FEV1 (p=0.006) in patients with high BMI in the PPI treatment group.

CONCLUSIONS: PPIs have no effect on the pulmonary function in patients with bronchiectasis and GERD. However, PPIs were noted to produce improvements in lung function in patients with bronchiectasis and high BMI.

Original languageEnglish
Pages (from-to)10-15
Number of pages6
JournalThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Volume68
Issue number1
DOIs
Publication statusPublished - 2016 Jul 25
Externally publishedYes

Fingerprint

Bronchiectasis
Proton Pump Inhibitors
Gastroesophageal Reflux
Lung
Respiratory Function Tests
Vital Capacity
Forced Expiratory Volume
Population Characteristics
Therapeutics
Thorax
Tomography
Research Personnel

Keywords

  • Bronchiectasis
  • Gastroesophageal reflux
  • Proton pump inhibitors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease. / Ahn, Byungkyu; Lee, Dong Ho; Lee, Chang Min; Hwang, Jae Jin; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung.

In: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, Vol. 68, No. 1, 25.07.2016, p. 10-15.

Research output: Contribution to journalArticle

Ahn, Byungkyu ; Lee, Dong Ho ; Lee, Chang Min ; Hwang, Jae Jin ; Yoon, Hyuk ; Shin, Cheol Min ; Park, Young Soo ; Kim, Nayoung. / Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease. In: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2016 ; Vol. 68, No. 1. pp. 10-15.
@article{3106549e1957405c8f8ae24a38a92e84,
title = "Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease",
abstract = "BACKGROUND/AIMS: Bronchiectasis is aggravated by gastroesophageal reflux disease (GERD) owing to micro aspiration. Some researchers note the effect of antireflux surgery in bronchiectasis with GERD. However, few have investigated the effects of medical antireflux therapy. We investigated the effect of proton pump inhibitors (PPIs) in bronchiectasis with GERD.METHODS: From March 2003 to May 2015, the clinical records of patients who had bronchiectasis with GERD were reviewed. Patients underwent an initial pulmonary function test (PFT) and chest computed tomography when diagnosed with bronchiectasis. One group with typical GERD symptoms was treated with PPIs, while the other group was not. Both groups underwent PFTs within six months after completing PPI therapy. Population characteristics and associations were compared between the groups.RESULTS: Two hundred and fifty-seven patients (124 male, 133 female; mean age 67.6±10.0 years) were included. There were no significant differences between the groups in terms of forced vital capacity (FVC; p=0.239), forced expiratory volume in one second (FEV1; p=0.555), or FEV1/FVC (p=0.374) after PPI therapy. However, there were significant improvements in FVC (p=0.002) and FEV1 (p=0.006) in patients with high BMI in the PPI treatment group.CONCLUSIONS: PPIs have no effect on the pulmonary function in patients with bronchiectasis and GERD. However, PPIs were noted to produce improvements in lung function in patients with bronchiectasis and high BMI.",
keywords = "Bronchiectasis, Gastroesophageal reflux, Proton pump inhibitors",
author = "Byungkyu Ahn and Lee, {Dong Ho} and Lee, {Chang Min} and Hwang, {Jae Jin} and Hyuk Yoon and Shin, {Cheol Min} and Park, {Young Soo} and Nayoung Kim",
year = "2016",
month = "7",
day = "25",
doi = "10.4166/kjg.2016.68.1.10",
language = "English",
volume = "68",
pages = "10--15",
journal = "The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi",
issn = "1598-9992",
publisher = "Korean Society of Gastroenterology",
number = "1",

}

TY - JOUR

T1 - Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease

AU - Ahn, Byungkyu

AU - Lee, Dong Ho

AU - Lee, Chang Min

AU - Hwang, Jae Jin

AU - Yoon, Hyuk

AU - Shin, Cheol Min

AU - Park, Young Soo

AU - Kim, Nayoung

PY - 2016/7/25

Y1 - 2016/7/25

N2 - BACKGROUND/AIMS: Bronchiectasis is aggravated by gastroesophageal reflux disease (GERD) owing to micro aspiration. Some researchers note the effect of antireflux surgery in bronchiectasis with GERD. However, few have investigated the effects of medical antireflux therapy. We investigated the effect of proton pump inhibitors (PPIs) in bronchiectasis with GERD.METHODS: From March 2003 to May 2015, the clinical records of patients who had bronchiectasis with GERD were reviewed. Patients underwent an initial pulmonary function test (PFT) and chest computed tomography when diagnosed with bronchiectasis. One group with typical GERD symptoms was treated with PPIs, while the other group was not. Both groups underwent PFTs within six months after completing PPI therapy. Population characteristics and associations were compared between the groups.RESULTS: Two hundred and fifty-seven patients (124 male, 133 female; mean age 67.6±10.0 years) were included. There were no significant differences between the groups in terms of forced vital capacity (FVC; p=0.239), forced expiratory volume in one second (FEV1; p=0.555), or FEV1/FVC (p=0.374) after PPI therapy. However, there were significant improvements in FVC (p=0.002) and FEV1 (p=0.006) in patients with high BMI in the PPI treatment group.CONCLUSIONS: PPIs have no effect on the pulmonary function in patients with bronchiectasis and GERD. However, PPIs were noted to produce improvements in lung function in patients with bronchiectasis and high BMI.

AB - BACKGROUND/AIMS: Bronchiectasis is aggravated by gastroesophageal reflux disease (GERD) owing to micro aspiration. Some researchers note the effect of antireflux surgery in bronchiectasis with GERD. However, few have investigated the effects of medical antireflux therapy. We investigated the effect of proton pump inhibitors (PPIs) in bronchiectasis with GERD.METHODS: From March 2003 to May 2015, the clinical records of patients who had bronchiectasis with GERD were reviewed. Patients underwent an initial pulmonary function test (PFT) and chest computed tomography when diagnosed with bronchiectasis. One group with typical GERD symptoms was treated with PPIs, while the other group was not. Both groups underwent PFTs within six months after completing PPI therapy. Population characteristics and associations were compared between the groups.RESULTS: Two hundred and fifty-seven patients (124 male, 133 female; mean age 67.6±10.0 years) were included. There were no significant differences between the groups in terms of forced vital capacity (FVC; p=0.239), forced expiratory volume in one second (FEV1; p=0.555), or FEV1/FVC (p=0.374) after PPI therapy. However, there were significant improvements in FVC (p=0.002) and FEV1 (p=0.006) in patients with high BMI in the PPI treatment group.CONCLUSIONS: PPIs have no effect on the pulmonary function in patients with bronchiectasis and GERD. However, PPIs were noted to produce improvements in lung function in patients with bronchiectasis and high BMI.

KW - Bronchiectasis

KW - Gastroesophageal reflux

KW - Proton pump inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85017510628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017510628&partnerID=8YFLogxK

U2 - 10.4166/kjg.2016.68.1.10

DO - 10.4166/kjg.2016.68.1.10

M3 - Article

C2 - 27443618

AN - SCOPUS:85017510628

VL - 68

SP - 10

EP - 15

JO - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

JF - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

SN - 1598-9992

IS - 1

ER -